Navigation Links
First ever large-scale study of ketamine users published
Date:11/16/2009

The first ever large-scale, longitudinal study of ketamine users has been published online today in the journal Addiction. With Ketamine (K, Special K) use increasing faster than any other drug in the UK (British Crime Survey, 2008) this research showing the consequences of repeated ketamine use provides valuable information for users and addiction professionals alike.

For the study, researchers from University College London followed 150 people over a year to see if changes in their ketamine use could predict changes in their psychological well-being, memory and concentration. Of these 150 people, 30 were taking large quantities of the drug nearly every day, 30 were taking it 'recreationally' (once or twice a month), 30 were former users, 30 used illicit drugs apart from ketamine and 30 did not use any illicit drugs.

The authors found that the heavy ketamine users were impaired on several measures, including verbal memory. Short term memory and visual memory in this group decreased over the year as ketamine use increased. These individuals also performed more poorly overall on verbal memory, displaying symptoms such as forgetfulness and experiencing difficulty recalling conversations and people's names.

The amount of increase in ketamine use over the course of one year was also a source of concern. Hair analysis showed that ketamine levels among recreational users doubled at follow-up compared to initial testing, a pattern seen with other addictive drugs. Ketamine levels in the frequent using group did not change across the year, but this group was already using up to ten grams per day at initial testing.

Interestingly, the recreational ketamine users and ex ketamine users did not differ from non-drug-taking controls on memory, attention and measures of psychological well-being, suggesting that occasional ketamine use does not lead to prolonged harms to cognitive function and that any damage may be reversed when people quit using the drug. However, all groups of ketamine users showed evidence of unusual beliefs or mild 'delusions', with these being greatest in the frequent users and least in ex-users (i.e. it appeared dependent on the amount of the drug used). It is not clear to what extent this is a pre-existing difference in ketamine users, something that develops from using the drug or a mixture of both.

Says lead author Dr. Celia Morgan: "These findings have implications for the growing number of ketamine users in the UK as well as addiction professionals who may encounter increasing numbers of ketamine dependent users. These findings suggest these frequent ketamine users will be impaired, albeit transiently, in a variety of psychological domains."


'/>"/>

Contact: Amy Molnar
amolnar@wiley.com
Wiley-Blackwell
Source:Eurekalert

Related medicine news :

1. First biomarker discovered that predicts prostate cancer outcome
2. FDA Approves First Anti-Psychotic for Kids
3. Single-incision belly-button surgery to remove kidney performed first at UT Southwestern
4. First study examines newly-licensed RN work attitudes and intentions
5. Glades General Hospital First in Palm Beach County to Provide On-Site Electronic Birth Registration
6. UHW Announces: Antelope Valley Hospital Caregivers and Board Vote to Ratify First Union Contract With SEIU UHW-West
7. Father and Daughter From Tanzania Receive Their First Medical Examination in Newport Beach
8. High and mighty: first common height gene identified by researchers behind obesity gene finding
9. APA Comments on FDAs First Approval of Medication to Treat Pediatric Schizophrenia and Bipolar Disorder
10. TriWest Creates First-of-its-Kind Partnership to Offer Military Leaders With Grief Support Program
11. Watson Receives First FDA Approval for Manufacturing Product at Its Goa, India Facility
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/7/2016)... Orion, Clarkston, Metamora, Michigan (PRWEB) , ... February ... ... to correct pelvic organ prolapse with the latest techniques and the most minimally ... risk for pelvic organ prolapse, particularly after menopause. Other risk factors include surgery ...
(Date:2/7/2016)... ... February 07, 2016 , ... ... MyDecision™ empowers employers and organizations with the tools and information to lower the ... elements to cut the cost of providing employee healthcare benefits by as much ...
(Date:2/6/2016)... ... February 06, 2016 , ... FOR ... AT AORN SURGICAL CONFERENCE & EXPO , WHAT:     , This conference is ... 5000 perioperative nurses in attendance to study the latest evidence-based recommendations and ...
(Date:2/6/2016)... ... February 06, 2016 , ... With the FCPX LUT: Summer ... to their footage. A LUT is a Lookup Table that contains a mathematical formula ... indicated by the table. By manipulating each pixel, LUT's can change each color range ...
(Date:2/6/2016)... ... 06, 2016 , ... Research has shown that building shame ... frequency and level of relapse. , At the 2016 iaedp Symposium, ... explore the critical tasks of the recovery phase and beyond including relapse prevention ...
Breaking Medicine News(10 mins):
(Date:2/8/2016)... NORRITON, Pa. , Feb. 8, 2016 /PRNewswire/ ... of November Research Group (NRG),s pharmacovigilance technology ... pharmacovigilance system-related consulting services and an Oracle Argus ... compliance services to Life Sciences companies. ... strengthens and expands HighPoint,s life sciences capabilities and ...
(Date:2/8/2016)... , Switzerland and PALO ALTO, Calif. , ... biological and chemical manufacturing, and Kodiak Sciences Inc., a ... treatment of retinal disease, announced today agreements for the ... Lonza will manufacture material at multiple sites, including Slough ... --> --> Retinal diseases, such ...
(Date:2/8/2016)... , Feb. 8, 2016  Avista Pharma Solutions ("Avista ... Setzer as Chief Financial Officer (CFO). Mr. Setzer is ... of experience in various roles within growing technology and ... served as the Executive Director of Finance at INC ... Raleigh, NC . Previously, Mr. Setzer served ...
Breaking Medicine Technology: